Organized by Pharma IQ, a division of IQPC,
the Anti-Infectives Summit will be held January 25-27, 2010 in
Philadelphia, PA (www.anti-infectivesummit.com).
This forum explores recent advances within anti-infective drug discovery
and development, and is geared towards Chief Scientific Officers and
Scientists working in microbiology, immunology, infectious diseases,
medicinal chemistry and drug development.
Combating drug resistant strains of viruses and bacteria has created
significant challenges for the pharmaceutical and biotech industries. As
the demand for new therapies increases, the Anti-Infectives Summit aims
to promote a more integrated approach to improving pipelines.
“What is really driving antibiotic discovery and research is real
medical need created by the obsolescence of the older classes of
antibiotics due to increasing resistance and/or adverse effects,” states Nachum
Kaplan, PhD, Vice President, Microbiology, Affinium
Pharmaceuticals and a featured speaker at the Summit.
The Anti-Infectives Summit showcases effective lead generation
approaches being used in anti-bacterial, anti-viral and anti-fungal drug
discovery, including case studies on: